{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:15:29Z","timestamp":1792883729925,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05382-x","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:26:38Z","timestamp":1777634798000},"page":"15629-15649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nootkatone as a multi-target modulator of the PD-L1\/PD-1 signaling in pancreatic cancer: network pharmacology, docking, molecular dynamics, and DFT analysis"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3367-613X","authenticated-orcid":false,"given":"Karan","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-5475","authenticated-orcid":false,"given":"Somdutt","family":"Mujwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"11","key":"5382_CR1","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3390\/pathogens12111369","volume":"12","author":"M Adnan","year":"2023","unstructured":"Adnan M, Siddiqui AJ, Ashraf SA, Bardakci F, Alreshidi M, Badraoui R, Noumi E, Tepe B, Sachidanandan M, Patel M (2023) Network pharmacology, molecular docking, and molecular dynamics simulation to elucidate the molecular targets and potential mechanism of Phoenix dactylifera (Ajwa Dates) against Candidiasis. Pathogens 12(11):1369. https:\/\/doi.org\/10.3390\/pathogens12111369","journal-title":"Pathogens"},{"issue":"5","key":"5382_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-01996-w","volume":"40","author":"S Agrawal","year":"2023","unstructured":"Agrawal S, Das R, Singh AK, Kumar P, Shukla PK, Bhattacharya I, Tripathi AK, Mishra SK, Tiwari KN (2023) Network pharmacology-based anti-pancreatic cancer potential of kaempferol and catechin of Trema orientalis L. through computational approach. Med Oncol 40(5):133. https:\/\/doi.org\/10.1007\/s12032-023-01996-w","journal-title":"Med Oncol"},{"issue":"13","key":"5382_CR3","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1080\/07391102.2024.2446672","volume":"43","author":"A Akoonjee","year":"2025","unstructured":"Akoonjee A, Lukman HY, Ajao AA, Uthman TO, Sabiu S (2025) A network pharmacology- and molecular dynamics simulation-based bioprospection of Khaya grandifoliola C. DC. for diabetes care. J Biomol Struct Dyn 43(13):7155\u20137174. https:\/\/doi.org\/10.1080\/07391102.2024.2446672","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"5382_CR4","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1039\/D3RA06297J","volume":"14","author":"K Bhattacharya","year":"2024","unstructured":"Bhattacharya K, Chandra Nath B, Ahmed E, Khanal P, Chanu NR, Deka S, Das D, Shrivastava AK (2024) Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer. RSC Adv 14(6):4188\u20134200. https:\/\/doi.org\/10.1039\/D3RA06297J","journal-title":"RSC Adv"},{"key":"5382_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101815","volume":"11","author":"UM Chandramohan","year":"2024","unstructured":"Chandramohan UM, Joseph D (2024) Hirshfeld surface, fukui function, molecular docking, molecular dynamics investigation on human immunodeficiency virus-1 (HIV) organism with 2,6-dibromo-4-chloroaniline. Results in Chemistry 11:101815. https:\/\/doi.org\/10.1016\/j.rechem.2024.101815","journal-title":"Results in Chemistry"},{"issue":"1","key":"5382_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13721-024-00444-7","volume":"13","author":"H Chen","year":"2024","unstructured":"Chen H, Li R, Ma X, Qiu Z, Qiu Y (2024) Network pharmacology and experimental validation to explore the anti-aging mechanism of action of betulinic acid. Network Modeling Analysis in Health Informatics and Bioinformatics 13(1):35. https:\/\/doi.org\/10.1007\/s13721-024-00444-7","journal-title":"Network Modeling Analysis in Health Informatics and Bioinformatics"},{"key":"5382_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2024.100567","volume":"14","author":"F Cheng","year":"2025","unstructured":"Cheng F, Ma Y, Qiu N, Yang Y, Shen Z, Lai X, Ge J, Guo Y (2025) Integrated network pharmacology, bioinformatics, and experimental approach to explore the mechanism of honokiol liposomes against glioblastoma. Pharmacological Research-Modern Chinese Medicine 14:100567. https:\/\/doi.org\/10.1016\/j.prmcm.2024.100567","journal-title":"Pharmacological Research-Modern Chinese Medicine"},{"key":"5382_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102422","volume":"16","author":"B Chibuye","year":"2025","unstructured":"Chibuye B, Singh IS, Chimuka L, Monyai M, Kakoma MK (2025) Computational insights into the anti-diabetic potential of Albizia antunesiana (Mimosaceae) metabolites: a molecular docking, drug-likeness and ADMET analysis. Results in Chemistry 16:102422. https:\/\/doi.org\/10.1016\/j.rechem.2025.102422","journal-title":"Results in Chemistry"},{"key":"5382_CR9","doi-asserted-by":"publisher","unstructured":"Chitluri KK, Arnold EI (2025) Integrative genomic analysis identifies DPP4 inhibition as a modulator of FGF17 and PDGFRA downregulation and PI3K\/Akt pathway suppression leading to apoptosis. Front Pharmacol\u00a016. https:\/\/doi.org\/10.3389\/fphar.2025.1606914","DOI":"10.3389\/fphar.2025.1606914"},{"issue":"1","key":"5382_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/biomedicines12010201","volume":"12","author":"P Chunarkar-Patil","year":"2024","unstructured":"Chunarkar-Patil P, Kaleem M, Mishra R, Ray S, Ahmad A, Verma D, Bhayye S, Dubey R, Singh H, Kumar S (2024) Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomedicines 12(1):201. https:\/\/doi.org\/10.3390\/biomedicines12010201","journal-title":"Biomedicines"},{"key":"5382_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116203","volume":"171","author":"J-W Cui","year":"2024","unstructured":"Cui J-W, Li Y, Yang Y, Yang H-K, Dong J-M, Xiao Z-H, He X, Guo J-H, Wang R-Q, Dai B, Zhou Z-L (2024) Tumor immunotherapy resistance: revealing the mechanism of PD-1\/PD-L1-mediated tumor immune escape. Biomed Pharmacother 171:116203. https:\/\/doi.org\/10.1016\/j.biopha.2024.116203","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5382_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/antiox12020370","volume":"12","author":"C Dai","year":"2023","unstructured":"Dai C, Liu M, Zhang Q, Das Gupta S, Tang S, Shen J (2023) Nootkatone supplementation attenuates carbon tetrachloride exposure-induced nephrotoxicity in mice. Antioxidants 12(2):370. https:\/\/doi.org\/10.3390\/antiox12020370","journal-title":"Antioxidants"},{"issue":"1","key":"5382_CR13","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s12672-025-03190-y","volume":"16","author":"I Debnath","year":"2025","unstructured":"Debnath I, Kundu M (2025) Therapeutic potential of natural compounds in targeting cancer stem cells: a promising approach for cancer treatment. Discov Oncol 16(1):1433. https:\/\/doi.org\/10.1007\/s12672-025-03190-y","journal-title":"Discov Oncol"},{"issue":"2","key":"5382_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12627","volume":"45","author":"X Diao","year":"2025","unstructured":"Diao X, Guo C, Jin Y, Li B, Gao X, Du X, Chen Z, Jo M, Zeng Y, Ding C, Liu W, Guo J, Li S, Qiu H (2025) Cancer situation in China: an analysis based on the global epidemiological data released in 2024. Cancer Commun 45(2):178\u2013197. https:\/\/doi.org\/10.1002\/cac2.12627","journal-title":"Cancer Commun"},{"key":"5382_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.11.008","author":"C Donz\u00e9","year":"2025","unstructured":"Donz\u00e9 C, Blay JY, Andr\u00e9 N (2025) Chemotherapy-free cancer treatment\u2013not for everyone yet. Trends Cancer. https:\/\/doi.org\/10.1016\/j.trecan.2025.11.008","journal-title":"Trends Cancer"},{"key":"5382_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2022.134135","volume":"1272","author":"A El Mansouri","year":"2023","unstructured":"El Mansouri A, Lachhab S, Oubella A, Mehdi A, Neyts J, Jochmans D, Chiu W, Vangeel L, De Jonghe S, Morjani H, Ali MA, Zahouily M, Sanghvi YS, Lazrek HB (2023) Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives. J Mol Struct 1272:134135. https:\/\/doi.org\/10.1016\/j.molstruc.2022.134135","journal-title":"J Mol Struct"},{"key":"5382_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2021.114490","volume":"177","author":"J Fan","year":"2022","unstructured":"Fan J, Liu Z, Xu S, Yan X, Cheng W, Yang R, Guo Y (2022) Non-food bioactive product (+)-nootkatone: chemistry and biological activities. Ind Crops Prod 177:114490. https:\/\/doi.org\/10.1016\/j.indcrop.2021.114490","journal-title":"Ind Crops Prod"},{"key":"5382_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/fft2.70151","author":"R Fatima","year":"2026","unstructured":"Fatima R, Prasher P, Sharma M, B\u00fcsselberg D, Figueroa\u2010Gonz\u00e1lez G, Reyes\u2010Hern\u00e1ndez OD, Villegas\u2010V\u00e1zquez EY, Cort\u00e9s H, Leyva\u2010G\u00f3mez G, Herrera\u2010Bravo J, Habtemariam S, Sharifi\u2010Rad J, Butnariu M, Berar C, Caunii A, Cho WC (2026) Natural products targeting Notch signaling in cancer: mechanistic insights and food\u2010based chemoprevention potential. Food Front. https:\/\/doi.org\/10.1002\/fft2.70151","journal-title":"Food Front"},{"issue":"46","key":"5382_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031787","volume":"101","author":"J Gai","year":"2022","unstructured":"Gai J, Xing J, Wang Y, Lei J, Zhang C, Zhang J, Tang J (2022) Exploration of potential targets and mechanisms of naringenin in treating Autism Spectrum Disorder via network pharmacology and molecular docking. Medicine Baltimore 101(46):e31787. https:\/\/doi.org\/10.1097\/MD.0000000000031787","journal-title":"Medicine Baltimore"},{"issue":"9","key":"5382_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092834","volume":"27","author":"C Gnanaraj","year":"2022","unstructured":"Gnanaraj C, Sekar M, Fuloria S, Swain SS, Gan SH, Chidambaram K, Rani NNIM, Balan T, Stephenie S, Lum PT, Jeyabalan S, Begum MY, Chandramohan V, Thangavelu L, Subramaniyan V, Fuloria NK (2022) In silico molecular docking analysis of Karanjin against Alzheimer\u2019s and Parkinson\u2019s diseases as a potential natural lead molecule for new drug design, development and therapy. Molecules 27(9):2834. https:\/\/doi.org\/10.3390\/molecules27092834","journal-title":"Molecules"},{"key":"5382_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104293","volume":"131","author":"D-D He","year":"2021","unstructured":"He D-D, Zhang X-K, Zhu X-Y, Huang F-F, Wang Z, Tu J-C (2021) Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction. Comput Biol Med 131:104293. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104293","journal-title":"Comput Biol Med"},{"issue":"27","key":"5382_CR22","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","volume":"27","author":"J-X Hu","year":"2021","unstructured":"Hu J-X, Zhao C-F, Chen W-B, Liu Q-C, Li Q-W, Lin Y-Y, Gao F (2021) Pancreatic cancer: a review of epidemiology, trend, and risk factors. World J Gastroenterol 27(27):4298\u20134321. https:\/\/doi.org\/10.3748\/wjg.v27.i27.4298","journal-title":"World J Gastroenterol"},{"key":"5382_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.153000","volume":"63","author":"LVM Hung","year":"2019","unstructured":"Hung LVM, Moon JY, Ryu J, Cho SK (2019) Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin. Phytomedicine 63:153000. https:\/\/doi.org\/10.1016\/j.phymed.2019.153000","journal-title":"Phytomedicine"},{"key":"5382_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156012","volume":"271","author":"MH Jamal","year":"2025","unstructured":"Jamal MH, Khan MN (2025) Developments in pancreatic cancer emerging therapies, diagnostic methods, and epidemiology. Pathol Res Pract 271:156012. https:\/\/doi.org\/10.1016\/j.prp.2025.156012","journal-title":"Pathol Res Pract"},{"key":"5382_CR25","doi-asserted-by":"publisher","unstructured":"Jamshidi S, Eghbalian A, Shojaei S, Taherkhani A, Feizi\u2010Dehnayebi M (2025) Flavonoids as promising Akt1 inhibitors in cancer medicine: insights from molecular docking, dynamics, <scp>DFT<\/scp> calculations, and in\u00a0vitro validation. Cancer Rep\u00a08(8). https:\/\/doi.org\/10.1002\/cnr2.70315","DOI":"10.1002\/cnr2.70315"},{"issue":"17","key":"5382_CR26","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2174\/1389557522666220214092005","volume":"22","author":"AK Jha","year":"2022","unstructured":"Jha AK, Gairola S, Kundu S, Doye P, Syed AM, Ram C, Kulhari U, Kumar N, Murty US, Sahu BD (2022) Biological activities, pharmacokinetics and toxicity of nootkatone: a review. Mini Rev Med Chem 22(17):2244\u20132259. https:\/\/doi.org\/10.2174\/1389557522666220214092005","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"5382_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99781-4","volume":"15","author":"W Jiang","year":"2025","unstructured":"Jiang W, Shi J, Zhu Y, Yin L, Song Y, Zhang J, Lin X, Zhong J, Lu Y, Ma Y (2025) A novel prognostic model based on migrasome-related LncRNAs for gastric cancer. Sci Rep 15(1):14572. https:\/\/doi.org\/10.1038\/s41598-025-99781-4","journal-title":"Sci Rep"},{"key":"5382_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chphi.2023.100418","volume":"8","author":"K Kaavin","year":"2024","unstructured":"Kaavin K, Naresh D, Yogeshkumar M, Krishna Prakash M, Janarthanan S, Murali Krishnan M, Malathi M (2024) In-silico DFT studies and molecular docking evaluation of benzimidazo methoxy quinoline-2-one ligand and its Co, Ni, Cu and Zn complexes as potential inhibitors of Bcl-2, Caspase-3, EGFR, mTOR, and PI3K, cancer-causing proteins. Chem Phys Impact 8:100418. https:\/\/doi.org\/10.1016\/j.chphi.2023.100418","journal-title":"Chem Phys Impact"},{"issue":"11","key":"5382_CR29","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","volume":"50","author":"R Kaur","year":"2023","unstructured":"Kaur R, Bhardwaj A, Gupta S (2023) Cancer treatment therapies: traditional to modern approaches to combat cancers. Mol Biol Rep 50(11):9663\u20139676. https:\/\/doi.org\/10.1007\/s11033-023-08809-3","journal-title":"Mol Biol Rep"},{"issue":"5","key":"5382_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ajoms.2020.01.002","volume":"32","author":"K Kawamura","year":"2020","unstructured":"Kawamura K, Daa T, Kawano K, Yokoyama S (2020) Activation of the RAS\/ERK signaling pathway by RASAL1 and its clinical significance in squamous cell carcinomas of the tongue. J Oral Maxillofac Surg Med Pathol 32(5):400\u2013405. https:\/\/doi.org\/10.1016\/j.ajoms.2020.01.002","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"issue":"9","key":"5382_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091515","volume":"22","author":"T Kim","year":"2017","unstructured":"Kim T, Shin S, Kim S, Bulitta J, Weon K-Y, Joo S, Ma E, Yoo S, Park G-Y, Kwon D, Jeong S, Lee D, Shin B (2017) Alterations in pharmacokinetics of gemcitabine and erlotinib by concurrent administration of Hyangsayukgunja-Tang, a gastroprotective herbal medicine. Molecules 22(9):1515. https:\/\/doi.org\/10.3390\/molecules22091515","journal-title":"Molecules"},{"issue":"7","key":"5382_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP (2021) Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol 18(7):493\u2013502. https:\/\/doi.org\/10.1038\/s41575-021-00457-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"5382_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102486","volume":"14","author":"T Koltai","year":"2022","unstructured":"Koltai T, Reshkin SJ, Carvalho TMA, Di Molfetta D, Greco MR, Alfarouk KO, Cardone RA (2022) Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review. Cancers 14(10):2486. https:\/\/doi.org\/10.3390\/cancers14102486","journal-title":"Cancers"},{"issue":"2","key":"5382_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s13402-026-01181-x","volume":"49","author":"Y Kui","year":"2026","unstructured":"Kui Y, Tong F, Zhang R, Dong X, Wang J (2026) Strategies to target PD-1\/PD-L1 in the tumor microenvironment. Cell Oncol 49(2):50. https:\/\/doi.org\/10.1007\/s13402-026-01181-x","journal-title":"Cell Oncol"},{"key":"5382_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/jimb\/kuab046","author":"X Li","year":"2021","unstructured":"Li X, Ren J-N, Fan G, Zhang L-L, Pan S-Y (2021) Advances on (+)-nootkatone microbial biosynthesis and its related enzymes. J Ind Microbiol Biotechnol. https:\/\/doi.org\/10.1093\/jimb\/kuab046","journal-title":"J Ind Microbiol Biotechnol"},{"issue":"7","key":"5382_CR36","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/biomedicines13071733","volume":"13","author":"Z Lin","year":"2025","unstructured":"Lin Z, Adeniran EA, Cai Y, Qureshi TA, Li D, Gong J, Li J, Pandol SJ, Jiang Y (2025) Early detection of pancreatic cancer: current advances and future opportunities. Biomedicines 13(7):1733. https:\/\/doi.org\/10.3390\/biomedicines13071733","journal-title":"Biomedicines"},{"issue":"14","key":"5382_CR37","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.1021\/acsomega.4c00079","volume":"9","author":"N Lohitha","year":"2024","unstructured":"Lohitha N, Kumar PH, Sarveswari S, Rathod S, Chaudhari S, Tamboli Y, Islam I, Vijayakumar V (2024) Synthesis, characterization, in silico DFT, molecular docking, and dynamics simulation studies of phenylhydrazono phenoxyquinolones for their hypoglycemic efficacy. ACS Omega 9(14):16384\u201316399. https:\/\/doi.org\/10.1021\/acsomega.4c00079","journal-title":"ACS Omega"},{"issue":"1","key":"5382_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12906-024-04356-x","volume":"24","author":"G Ma","year":"2024","unstructured":"Ma G, Dong Q, Li F, Jin Z, Pi J, Wu W, Li J (2024) Network pharmacology and in vivo evidence of the pharmacological mechanism of geniposide in the treatment of atherosclerosis. BMC Complement Med Ther 24(1):53. https:\/\/doi.org\/10.1186\/s12906-024-04356-x","journal-title":"BMC Complement Med Ther"},{"key":"5382_CR39","doi-asserted-by":"publisher","unstructured":"Mandawade A, Pardeshi P, Khairnar S, Sonawane G, Mahajan S (2025) In silico drug-likeness, ADMET, toxicity profiling of clinically relevant antidiabetic agents.\u00a0Asian J Res Chem pp\u00a0235\u2013242. https:\/\/doi.org\/10.52711\/0974-4150.2025.00036","DOI":"10.52711\/0974-4150.2025.00036"},{"key":"5382_CR40","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70035","author":"A Mannucci","year":"2025","unstructured":"Mannucci A, Goel A (2025) Advances in pancreatic cancer early diagnosis, prevention, and treatment: the past, the present, and the future. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.70035","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5382_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/cimb47030193","volume":"47","author":"EJ Millan-Casarrubias","year":"2025","unstructured":"Millan-Casarrubias EJ, Garc\u00eda-Tejeda YV, Gonz\u00e1lez-De la Rosa CH, Ruiz-Maz\u00f3n L, Hern\u00e1ndez-Rodr\u00edguez YM, Cigarroa-Mayorga OE (2025) Molecular docking and pharmacological in silico evaluation of camptothecin and related ligands as promising HER2-targeted therapies for breast cancer. Curr Issues Mol Biol 47(3):193. https:\/\/doi.org\/10.3390\/cimb47030193","journal-title":"Curr Issues Mol Biol"},{"key":"5382_CR42","doi-asserted-by":"publisher","unstructured":"Mir WR, Bhat BA, Kumar A, Dhiman R, Alkhanani M, Almilaibary A, Dar MY, Ganie SA, Mir MA (2023) Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. Front Pharmacol\u00a014. https:\/\/doi.org\/10.3389\/fphar.2023.1135898","DOI":"10.3389\/fphar.2023.1135898"},{"issue":"4","key":"5382_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.15386\/mpr-2116","volume":"94","author":"A Mucileanu","year":"2021","unstructured":"Mucileanu A, Chira R, Mircea PA (2021) PD-1\/PD-L1 expression in pancreatic cancer and its implication in novel therapies. Med Pharm Rep 94(4):402\u2013410. https:\/\/doi.org\/10.15386\/mpr-2116","journal-title":"Med Pharm Rep"},{"issue":"8","key":"5382_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082276","volume":"12","author":"Z Nouri","year":"2020","unstructured":"Nouri Z, Fakhri S, Nouri K, Wallace CE, Farzaei MH, Bishayee A (2020) Targeting multiple signaling pathways in cancer: the rutin therapeutic approach. Cancers 12(8):2276. https:\/\/doi.org\/10.3390\/cancers12082276","journal-title":"Cancers"},{"issue":"1","key":"5382_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/japtr.japtr_143_21","volume":"13","author":"A Purnama","year":"2022","unstructured":"Purnama A, Rizki DR, Qanita I, Iqhrammullah M, Ahmad K, Mardina V, Puspita K, Hasballah K (2022) Molecular docking investigation of calotropone as a potential natural therapeutic agent against pancreatic cancer. J Adv Pharm Technol Res 13(1):44\u201349. https:\/\/doi.org\/10.4103\/japtr.japtr_143_21","journal-title":"J Adv Pharm Technol Res"},{"issue":"3","key":"5382_CR46","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s11030-021-10188-5","volume":"25","author":"H Rai","year":"2021","unstructured":"Rai H, Barik A, Singh YP, Suresh A, Singh L, Singh G, Nayak UY, Dubey VK, Modi G (2021) Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET\/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19. Mol Divers 25(3):1905\u20131927. https:\/\/doi.org\/10.1007\/s11030-021-10188-5","journal-title":"Mol Divers"},{"issue":"4","key":"5382_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s40828-024-00191-2","volume":"10","author":"R Ramachanderan","year":"2024","unstructured":"Ramachanderan R, Schaefer B (2024) (+)-Nootkatone, the flavor of grapefruit. ChemTexts 10(4):11. https:\/\/doi.org\/10.1007\/s40828-024-00191-2","journal-title":"ChemTexts"},{"key":"5382_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107032","volume":"110","author":"R Sharma","year":"2025","unstructured":"Sharma R, Komal K, Kumar S, Ghosh R, Kumar M (2025) A comprehensive review on revolutionizing pancreatic cancer treatment: liposomal innovations. J Drug Deliv Sci Technol 110:107032. https:\/\/doi.org\/10.1016\/j.jddst.2025.107032","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"5382_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/0115665232364196250131102330","volume":"26","author":"R Sharma","year":"2026","unstructured":"Sharma R, Kumar S, Ghosh R, Komal K, Kumar M (2026) Gene therapy: transforming the battle against pancreatic cancer. Curr Gene Ther 26(1):152\u2013159. https:\/\/doi.org\/10.2174\/0115665232364196250131102330","journal-title":"Curr Gene Ther"},{"issue":"20","key":"5382_CR50","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033521","volume":"102","author":"X Shi","year":"2023","unstructured":"Shi X, Huang B, Zhu J, Yamaguchi T, Hu A, Tabuchi M, Watanabe D, Yoshikawa S, Mizushima S, Mizushima A, Xia S (2023) A network pharmacology-based investigation of emodin against pancreatic adenocarcinoma. Medicine Baltimore 102(20):e33521. https:\/\/doi.org\/10.1097\/MD.0000000000033521","journal-title":"Medicine Baltimore"},{"issue":"1","key":"5382_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2024-001544","volume":"12","author":"S Shou","year":"2025","unstructured":"Shou S, Liu R, He J, Jiang X, Liu F, Li Y, Zhang X, En G, Pu Z, Hua B, Pang B, Zhang X (2025) Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the cancer incidence in five continents database. BMJ Open Gastroenterol 12(1):e001544. https:\/\/doi.org\/10.1136\/bmjgast-2024-001544","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"5382_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA Cancer J Clin"},{"key":"5382_CR53","doi-asserted-by":"publisher","unstructured":"Singh K, Shishodia G, Koul HK (2021) Pancreatic cancer: genetics, disease progression, therapeutic resistance and treatment strategies. J Cancer Metastasis and Treat. https:\/\/doi.org\/10.20517\/2394-4722.2021.96","DOI":"10.20517\/2394-4722.2021.96"},{"issue":"10485","key":"5382_CR54","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A, Koerkamp BG, Seufferlein T, Wilmink JW, Besselink MG (2025) Pancreatic cancer. Lancet 405(10485):1182\u20131202. https:\/\/doi.org\/10.1016\/S0140-6736(25)00261-2","journal-title":"Lancet"},{"issue":"1","key":"5382_CR55","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s43088-024-00552-3","volume":"13","author":"D Syahputra","year":"2024","unstructured":"Syahputra D, Ysrafil Y, Alexandra FD, Praja RK, Fatmaria F, Pratika RA (2024) Network pharmacology combined with molecular docking and molecular dynamics to verify the therapeutic potential of mung beans (Vigna radiata) against prostate cancer. Beni-Suef Univ J Basic Appl Sci 13(1):100. https:\/\/doi.org\/10.1186\/s43088-024-00552-3","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"1","key":"5382_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/13816128113199990470","volume":"20","author":"J Tang","year":"2014","unstructured":"Tang J, Aittokallio T (2014) Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles. Curr Pharm des 20(1):23\u201336. https:\/\/doi.org\/10.2174\/13816128113199990470","journal-title":"Curr Pharm des"},{"issue":"1","key":"5382_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58877-z","volume":"14","author":"A Vikhar Danish Ahmad","year":"2024","unstructured":"Vikhar Danish Ahmad A, Khan SW, Ali SA, Yasar Q (2024) Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety. Sci Rep 14(1):9799. https:\/\/doi.org\/10.1038\/s41598-024-58877-z","journal-title":"Sci Rep"},{"key":"5382_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.comtox.2021.100157","volume":"18","author":"MC Vlasiou","year":"2021","unstructured":"Vlasiou MC, Pafti KS (2021) Screening possible drug molecules for Covid-19. The example of vanadium (III\/IV\/V) complex molecules with computational chemistry and molecular docking. Comput Toxicol 18:100157. https:\/\/doi.org\/10.1016\/j.comtox.2021.100157","journal-title":"Comput Toxicol"},{"key":"5382_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.895738","author":"F Wang","year":"2022","unstructured":"Wang F, Bai J, Li F, Liu J, Wang Y, Li N, Wang Y, Xu J, Liu W, Xu L, Chen L (2022) Investigation of the mechanism of the anti-cancer effects of Astragalus propinquus Schischkin and Pinellia pedatisecta Schott (A&P) on melanoma via network pharmacology and experimental verification. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.895738","journal-title":"Front Pharmacol"},{"issue":"8","key":"5382_CR60","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.ajpath.2017.04.009","volume":"187","author":"J Wang","year":"2017","unstructured":"Wang J, Xu-Monette ZY, Jabbar KJ, Shen Q, Manyam GC, Tzankov A, Visco C, Wang J, Montes-Moreno S, Dybk\u00e6r K, Tam W, Bhagat G, Hsi ED, van Krieken JH, Ponzoni M, Ferreri AJM, Wang S, M\u00f8ller MB, Piris MA, Medeiros LJ, Li Y, Pham LV, Young KH (2017) AKT hyperactivation and the potential of AKT-targeted therapy in diffuse large B-cell lymphoma. Am J Pathol 187(8):1700\u20131716. https:\/\/doi.org\/10.1016\/j.ajpath.2017.04.009","journal-title":"Am J Pathol"},{"issue":"6","key":"5382_CR61","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3892\/mmr.2024.13356","volume":"30","author":"N Wang","year":"2024","unstructured":"Wang N, Cui J, Sun Z, Chen F, He X (2024) Exploring the protective effect and molecular mechanism of betulin in Alzheimer\u2019s disease based on network pharmacology, molecular docking and experimental validation. Mol Med Rep 30(6):232. https:\/\/doi.org\/10.3892\/mmr.2024.13356","journal-title":"Mol Med Rep"},{"key":"5382_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105739","volume":"147","author":"C Xiang","year":"2022","unstructured":"Xiang C, Chen C, Li X, Wu Y, Xu Q, Wen L, Xiong W, Liu Y, Zhang T, Dou C, Ding X, Hu L, Chen F, Yan Z, Liang L, Wei G (2022) Computational approach to decode the mechanism of curcuminoids against neuropathic pain. Comput Biol Med 147:105739. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105739","journal-title":"Comput Biol Med"},{"issue":"42","key":"5382_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040118","volume":"103","author":"Z Yang","year":"2024","unstructured":"Yang Z, Li J, Song H, Wu H, Zhang S, Mei Z, Xue Y, Zhang X, Yan C, Han Y (2024) Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of Guanxin Shutong capsule in treating heart failure. Medicine (Baltimore) 103(42):e40118. https:\/\/doi.org\/10.1097\/MD.0000000000040118","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"5382_CR64","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1002\/ptr.7552","volume":"36","author":"Z Yao","year":"2022","unstructured":"Yao Z, Li J, Bian L, Li Q, Wang X, Yang X, Wei X, Wan G, Wang Y, Shi J, Guo J (2022) Nootkatone alleviates rotenone-induced Parkinson\u2019s disease symptoms through activation of the <scp>PI3K<\/scp> \/Akt signaling pathway. Phytother Res 36(11):4183\u20134200. https:\/\/doi.org\/10.1002\/ptr.7552","journal-title":"Phytother Res"},{"key":"5382_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.909280","author":"Z Yong","year":"2022","unstructured":"Yong Z, Zibao H, Zhi Z, Ning M, Ruiqi W, Mimi C, Xiaowen H, Lin D, Zhixuan X, Qiang L, Weiying L, Xiaopo Z (2022) Nootkatone, a sesquiterpene ketone from alpiniae oxyphyllae fructus, ameliorates metabolic-associated fatty liver by regulating AMPK and MAPK signaling. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.909280","journal-title":"Front Pharmacol"},{"issue":"1","key":"5382_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07379-y","volume":"20","author":"E Yoo","year":"2020","unstructured":"Yoo E, Lee J, Lertpatipanpong P, Ryu J, Kim C-T, Park E-Y, Baek SJ (2020) Anti-proliferative activity of A. Oxyphylla and its bioactive constituent nootkatone in colorectal cancer cells. BMC Cancer 20(1):881. https:\/\/doi.org\/10.1186\/s12885-020-07379-y","journal-title":"BMC Cancer"},{"issue":"1","key":"5382_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13471-y","volume":"25","author":"W Yu","year":"2025","unstructured":"Yu W, Zhou D, Meng F, Wang J, Wang B, Qiang J, Shen L, Wang M, Fang H (2025) The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021. BMC Cancer 25(1):186. https:\/\/doi.org\/10.1186\/s12885-025-13471-y","journal-title":"BMC Cancer"},{"issue":"1","key":"5382_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1021\/acs.jafc.2c07543","volume":"71","author":"L-L Zhang","year":"2023","unstructured":"Zhang L-L, Chen Y, Li Z-J, Fan G, Li X (2023) Production, function, and applications of the sesquiterpenes valencene and nootkatone: a comprehensive review. J Agric Food Chem 71(1):121\u2013142. https:\/\/doi.org\/10.1021\/acs.jafc.2c07543","journal-title":"J Agric Food Chem"},{"key":"5382_CR69","doi-asserted-by":"publisher","unstructured":"Zhang X, Qi B, Chen J (2025) Clinical application and drug resistance mechanism of gemcitabine. Front Cell Dev Biol 13. https:\/\/doi.org\/10.3389\/fcell.2025.1702720","DOI":"10.3389\/fcell.2025.1702720"},{"issue":"35","key":"5382_CR70","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039454","volume":"103","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ji P, Xiao X, Wang J, Wan Z, Cao H, Kong L, Jin Y (2024) Network pharmacology, molecular docking, and molecular dynamics simulations shed light on the mechanism behind Gynostemma pentaphyllum\u2019s efficacy against osteosarcoma. Medicine (Baltimore) 103(35):e39454. https:\/\/doi.org\/10.1097\/MD.0000000000039454","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"5382_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17101607","volume":"17","author":"J Zottl","year":"2025","unstructured":"Zottl J, Sebesta CG, Tomosel E, Sebesta M-C, Sebesta C (2025) Unraveling the burden of pancreatic cancer in the 21st century: trends in incidence, mortality, survival, and key contributing factors. Cancers (Basel) 17(10):1607. https:\/\/doi.org\/10.3390\/cancers17101607","journal-title":"Cancers (Basel)"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05382-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:02:07Z","timestamp":1784775727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05382-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5382"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05382-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}